- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有53家主力机构披露2025-12-31报告期持股数据，持仓量总计855.82万股，占流通A股6.21%
- 波段诊断：
-
技术面诊股
诊断结果：4.8技术面打败了32%的股票
技术面评分前10的股票
近期的平均成本为16.83元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为16.83元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"16.83","date":1774929531,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2026.03.31","stock":"-1.19","trade":null,"ind":"-1.81"},{"date":"2026.03.30","stock":"0.12","trade":null,"ind":"-0.25"},{"date":"2026.03.27","stock":"4.70","trade":null,"ind":"1.13"},{"date":"2026.03.26","stock":"-2.62","trade":null,"ind":"-1.41"},{"date":"2026.03.25","stock":"1.86","trade":null,"ind":"1.95"},{"date":"2026.03.24","stock":"4.89","trade":null,"ind":"1.43"},{"date":"2026.03.23","stock":"-6.52","trade":null,"ind":"-3.76"},{"date":"2026.03.20","stock":"-4.09","trade":null,"ind":"-0.25"},{"date":"2026.03.19","stock":"-2.62","trade":null,"ind":"-2.02"},{"date":"2026.03.18","stock":"2.03","trade":null,"ind":"1.05"},{"date":"2026.03.17","stock":"-1.37","trade":null,"ind":"-1.87"},{"date":"2026.03.16","stock":"-0.34","trade":null,"ind":"0.19"},{"date":"2026.03.13","stock":"0.23","trade":null,"ind":"-0.65"},{"date":"2026.03.12","stock":"-1.35","trade":null,"ind":"-0.63"},{"date":"2026.03.11","stock":"-1.23","trade":null,"ind":"0.78"},{"date":"2026.03.10","stock":"2.45","trade":null,"ind":"2.04"},{"date":"2026.03.09","stock":"-1.02","trade":null,"ind":"-0.74"},{"date":"2026.03.06","stock":"2.91","trade":null,"ind":"0.59"},{"date":"2026.03.05","stock":"1.65","trade":null,"ind":"1.23"},{"date":"2026.03.04","stock":"-1.46","trade":null,"ind":"-0.75"},{"date":"2026.03.03","stock":"-3.27","trade":null,"ind":"-3.07"}]
透景生命,深证成指,医疗器械指数
压力支撑
该股压力位为16.73元，支撑位为16.44元。
[{"text":"\u538b\u529b\u4f4d","value":"16.73","date":1774886400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"16.44","date":1774886400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.9资金面打败了40%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月01日 12:47
| 机构今日流向(万元) | -743.08 | 机构5日流向(万元) | -1054.09 |
| 机构10日流向(万元) | -3706.93 | 机构20日流向(万元) | -6381.21 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2540.79万股，其中基金净增仓2家，主力净减仓24家，暂未发现中长期投资价值。
截止2025-12-31，共53家主力机构（基金53家），持仓量总计855.82万股，占流通A股6.21%
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 55.83万股
减仓：10家 ，减持 14.58万股
新出现在主力名单中：30家 ，持有629.08万股
从主力名单中消失：54家 ，原持有3211.12万股
其中，基金持仓与2025-06-30相比：
增仓：12家 ，增持 55.83万股
减仓：10家 ，减持 14.58万股
新出现在主力名单中：30家 ，持有629.08万股
从主力名单中消失：54家 ，原持有3211.12万股
消息面诊股
诊断结果：1.1消息面打败了0%的股票
今日有利好新闻的公司
近期该股利空消息较多，投资时需谨慎。
更多>>个股资讯
- 透景生命：子公司透景诊断再次通过高新技术企业认定
2026-03-27 - 透景生命注册资本减少事项已完成相关工商变更登记
2026-03-06 - 透景生命子公司取得2项医疗器械注册证
2026-03-05 - WHX Labs Dubai 2026丨透景集团携
2026-02-13 - 透景生命：预计2025年净利润同比下降83.90%
2026-01-29 - 市器审中心领导一行莅临上海透景生命调研指导 共促I
2026-01-28 - 概念动态|透景生命新增“AI应用”概念
2026-01-27 - 透景生命获得1项发明专利证书 涉及荧光定量检测领域
2026-01-26 - 尼帕病毒疫情催化A股防疫板块异动：检测、疫苗、耗材
2026-01-26 - 概念细分|透景生命(300642)新归类于流感-流
2026-01-26
消息列表
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-01-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-27 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-28 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2025-04-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了3%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.03.31","price":"-1.81","value":null},{"date":"2026.03.30","price":"-0.25","value":null},{"date":"2026.03.27","price":"1.13","value":null},{"date":"2026.03.26","price":"-1.41","value":null},{"date":"2026.03.25","price":"1.95","value":null},{"date":"2026.03.24","price":"1.43","value":null},{"date":"2026.03.23","price":"-3.76","value":null},{"date":"2026.03.20","price":"-0.25","value":null},{"date":"2026.03.19","price":"-2.02","value":null},{"date":"2026.03.18","price":"1.05","value":null},{"date":"2026.03.17","price":"-1.87","value":null},{"date":"2026.03.16","price":"0.19","value":null},{"date":"2026.03.13","price":"-0.65","value":null},{"date":"2026.03.12","price":"-0.63","value":null},{"date":"2026.03.11","price":"0.78","value":null},{"date":"2026.03.10","price":"2.04","value":null},{"date":"2026.03.09","price":"-0.74","value":null},{"date":"2026.03.06","price":"0.59","value":null},{"date":"2026.03.05","price":"1.23","value":null},{"date":"2026.03.04","price":"-0.75","value":null},{"date":"2026.03.03","price":"-3.07","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 九安医疗 | 45.70% | 20.92% | 5.3分 |
| 2 | 蓝帆医疗 | 33.56% | 1.53% | 5.4分 |
| 3 | 康拓医疗 | 31.47% | 9.11% | 5.8分 |
| 4 | 海泰新光 | 29.90% | 46.03% | 5.7分 |
| 5 | 英科医疗 | 29.31% | 2.95% | 5.2分 |
| 6 | 基蛋生物 | 20.87% | 11.21% | 5.4分 |
| 8 | 奥美医疗 | 15.66% | -0.91% | 5.1分 |
| 10 | 康众医疗 | 14.19% | 11.49% | 5.2分 |
| 12 | 南卫股份 | 11.55% | 1.44% | 5.5分 |
| 14 | 国发股份 | 6.69% | 3.08% | 4.7分 |
| 16 | 威高骨科 | 5.95% | 11.64% | 5.7分 |
| 18 | 维力医疗 | 5.74% | -0.80% | 5.5分 |
| 20 | 福瑞医科 | 5.06% | 7.50% | 5.8分 |
| 22 | 济民健康 | 4.32% | 0.45% | 5.0分 |
| 24 | 英诺特 | 4.10% | -0.77% | 4.5分 |
| 26 | 万泰生物 | 2.71% | -1.22% | 4.4分 |
| 28 | 利德曼 | 1.66% | 4.51% | 4.6分 |
| 30 | 仁度生物 | 1.14% | 4.34% | 5.7分 |
| 32 | 凯普生物 | 0.48% | -0.16% | 4.3分 |
| 34 | 力诺药包 | 0.35% | 6.97% | 5.0分 |
| 36 | 南微医学 | -0.18% | 1.62% | 5.4分 |
| 38 | 东方生物 | -0.35% | 0.75% | 4.9分 |
| 40 | 北芯生命 | -0.37% | 0.88% | 4.6分 |
| 42 | 赛诺医疗 | -0.54% | 0.99% | 4.9分 |
| 44 | 达安基因 | -0.84% | 0.34% | 5.2分 |
| 46 | 海利生物 | -1.28% | 4.04% | 4.2分 |
| 48 | 冠昊生物 | -1.43% | -6.16% | 4.5分 |
| 50 | 开立医疗 | -1.77% | 6.99% | 5.0分 |
| 52 | 东星医疗 | -2.31% | 3.34% | 4.4分 |
| 54 | 康德莱 | -2.69% | 3.33% | 5.5分 |
| 56 | 美康生物 | -3.21% | 1.26% | 4.5分 |
| 58 | 透景生命 | -3.67% | 2.73% | 3.4分 |
| 60 | 拱东医疗 | -3.77% | 1.11% | 5.2分 |
| 62 | 佰仁医疗 | -4.23% | 3.90% | 5.2分 |
| 64 | 新华医疗 | -4.48% | 0.92% | 4.5分 |
| 66 | 威高血净 | -4.61% | -0.86% | 5.4分 |
| 68 | 之江生物 | -4.74% | -0.16% | 4.1分 |
| 70 | 洁特生物 | -4.81% | 2.88% | 5.4分 |
| 72 | 安图生物 | -5.21% | 0.94% | 5.2分 |
| 74 | 山外山 | -5.29% | 3.94% | 6.5分 |
| 76 | 九强生物 | -5.59% | 1.11% | 4.1分 |
| 78 | 五洲医疗 | -6.07% | 3.22% | 4.4分 |
| 80 | 新产业 | -6.09% | -1.86% | 5.1分 |
| 82 | 微电生理 | -6.20% | 5.38% | 4.8分 |
| 84 | 港通医疗 | -6.37% | 4.88% | 5.0分 |
| 86 | 健帆生物 | -6.73% | -0.06% | 4.9分 |
| 88 | 天益医疗 | -6.75% | 0.17% | 5.0分 |
| 90 | 大博医疗 | -6.99% | 4.61% | 5.0分 |
| 92 | 理邦仪器 | -7.17% | -4.32% | 5.4分 |
| 94 | 博拓生物 | -7.44% | -3.05% | 4.0分 |
| 96 | 赛科希德 | -7.54% | 3.33% | 5.1分 |
| 98 | 普门科技 | -7.79% | -1.05% | 4.7分 |
| 100 | 天臣医疗 | -7.97% | 4.03% | 5.5分 |
| 102 | 翔宇医疗 | -8.15% | 1.96% | 4.5分 |
| 104 | 楚天科技 | -8.37% | 2.17% | 4.9分 |
| 106 | 瑞迈特 | -8.49% | 0.66% | 4.8分 |
| 108 | 硕世生物 | -8.58% | -6.78% | 3.8分 |
| 110 | 戴维医疗 | -8.86% | 0.72% | 5.8分 |
| 112 | 欧普康视 | -8.96% | -0.84% | 4.5分 |
| 114 | 爱博医疗 | -9.29% | 2.23% | 5.2分 |
| 116 | 西山科技 | -9.69% | -0.35% | 4.9分 |
| 118 | 美好医疗 | -10.65% | 2.17% | 5.5分 |
| 120 | 澳华内镜 | -10.85% | -0.43% | 4.5分 |
| 122 | 联影医疗 | -10.98% | -0.85% | 5.0分 |
| 124 | 浩欧博 | -12.53% | -1.68% | 5.0分 |
| 126 | - | -12.86% | 0.76% | 分 |
| 128 | 采纳股份 | -13.20% | -5.48% | 4.4分 |
| 130 | 东富龙 | -14.49% | 2.44% | 4.3分 |
| 132 | - | -15.43% | -3.28% | 分 |
| 134 | - | -16.33% | 0.11% | 分 |
| 136 | - | -17.63% | -3.70% | 分 |
| 138 | - | -18.19% | -5.12% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 97/242 ， 34/242。
[{"date":"2025-09-30","value":"0.39","vol":"2.98"},{"date":"2025-06-30","value":"0.18","vol":"2.34"},{"date":"2025-03-31","value":"0.03","vol":"1.16"},{"date":"2024-12-31","value":"2.27","vol":"0.56"},{"date":"2024-09-30","value":"1.61","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.39 | 0.18 | 0.03 | 2.27 | 1.61 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"66.60","vol":"51.74"},{"date":"2025-06-30","value":"65.66","vol":"52.05"},{"date":"2025-03-31","value":"63.66","vol":"51.42"},{"date":"2024-12-31","value":"66.15","vol":"52.52"},{"date":"2024-09-30","value":"64.94","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
66.60 | 65.66 | 63.66 | 66.15 | 64.94 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 111/242 ， 105/242。
[{"date":"2025-09-30","value":"-19.73","vol":"0.26"},{"date":"2025-06-30","value":"-26.25","vol":"-1.09"},{"date":"2025-03-31","value":"-19.53","vol":"-0.12"},{"date":"2024-12-31","value":"-19.53","vol":"1.15"},{"date":"2024-09-30","value":"-20.01","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-19.73 | -26.25 | -19.53 | -19.53 | -20.01 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-76.33","vol":"-15.37"},{"date":"2025-06-30","value":"-58.41","vol":"-18.14"},{"date":"2025-03-31","value":"110.51","vol":"-2.59"},{"date":"2024-12-31","value":"-61.37","vol":"-23.09"},{"date":"2024-09-30","value":"-43.16","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-76.33 | -58.41 | 110.51 | -61.37 | -43.16 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 103/242 ， 107/242。
[{"date":"2025-09-30","value":"0.14","vol":"0.25"},{"date":"2025-06-30","value":"0.09","vol":"0.17"},{"date":"2025-03-31","value":"0.04","vol":"0.08"},{"date":"2024-12-31","value":"0.25","vol":"0.36"},{"date":"2024-09-30","value":"0.19","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.09 | 0.04 | 0.25 | 0.19 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.79","vol":"1.66"},{"date":"2025-06-30","value":"0.52","vol":"1.12"},{"date":"2025-03-31","value":"0.25","vol":"0.55"},{"date":"2024-12-31","value":"1.09","vol":"2.32"},{"date":"2024-09-30","value":"0.78","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.79 | 0.52 | 0.25 | 1.09 | 0.78 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"37.37","vol":"14.74"},{"date":"2025-06-30","value":"59.24","vol":"15.17"},{"date":"2025-03-31","value":"21.91","vol":"4.22"},{"date":"2024-12-31","value":"46.09","vol":"29.38"},{"date":"2024-09-30","value":"25.84","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 37.37 | 59.24 | 21.91 | 46.09 | 25.84 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.20","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.20","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.20 | - | 1.20 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 113/242 ， 116/242。
[{"date":"2025-09-30","value":"11.00","vol":"5.66"},{"date":"2025-06-30","value":"8.26","vol":"5.47"},{"date":"2025-03-31","value":"13.95","vol":"5.84"},{"date":"2024-12-31","value":"7.00","vol":"5.30"},{"date":"2024-09-30","value":"10.47","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
11.00 | 8.26 | 13.95 | 7.00 | 10.47 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"9.18","vol":"4.51"},{"date":"2025-06-30","value":"6.90","vol":"4.35"},{"date":"2025-03-31","value":"11.08","vol":"4.73"},{"date":"2024-12-31","value":"5.45","vol":"4.27"},{"date":"2024-09-30","value":"8.59","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
9.18 | 6.90 | 11.08 | 5.45 | 8.59 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 50/242 ， 50/242。
[{"date":"2025-09-30","value":"23.63","vol":"22.07"},{"date":"2025-06-30","value":"13.17","vol":"22.01"},{"date":"2025-03-31","value":"10.33","vol":"21.19"},{"date":"2024-12-31","value":"13.20","vol":"21.94"},{"date":"2024-09-30","value":"9.82","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.63 | 13.17 | 10.33 | 13.20 | 9.82 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.32","vol":"0.71"},{"date":"2025-06-30","value":"0.15","vol":"0.58"},{"date":"2025-03-31","value":"0.12","vol":"0.56"},{"date":"2024-12-31","value":"0.15","vol":"0.55"},{"date":"2024-09-30","value":"0.11","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.32 | 0.15 | 0.12 | 0.15 | 0.11 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"1.61","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.25","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.89","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.35","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.09","blueLineValue":"0.05","type":"YC"}]